According to Barinthus Biotherapeutics's latest financial reports the company's current revenue (TTM ) is A$23.69 Million. In 2023 the company made a revenue of A$1.17 Million a decrease over the revenue in the year 2022 that were of A$65.69 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.